Point Of Care Diagnostics & Testing Market Hit $36.70 Bn 2030

The Point Of Care Diagnostics & Testing market size is predicted to hit around US$ 36.70 billion by 2030 and is expected to grow at a compound annual growth rate (CAGR) of 3.33% from 2022 to 2030.

Get Sample Copy of This [email protected] https://www.visionresearchreports.com/report/sample/37242

Growth Factors

Point of care (POC) diagnostics & testing has significantly altered the therapeutic models applied for the treatment of diabetic patients, HIV patients, and patients with Cardiovascular Disorders (CVDs), in recent years. In addition, emerging advancements on the horizon are projected to enhance the near-patient treatment workflows for infectious diseases, strokes, and cancer.

The industry is set to witness lucrative growth as POC testing serves as a profitable alternative to traditional laboratory tests. Point-of-care devices are designed to offer actionable information at the location and time of patient care, which enables early diagnosis of diseases. The advent of non-invasive & minimally invasive POC devices, continuous POCT, miniaturized technologies, and the adoption of telemedicine in remote patient monitoring are some of the key trends contributing to the market growth.

Moreover, the advent of rapid data sharing solutions as well as platforms is set to contribute to the development of POC COVID-19 tests, supplementing the overall market growth. Companies actively working toward the development of such rapid data sharing solutions include Foundation for Innovative New Diagnostics (FIND) and 360 Dx. The rising number of such companies is set to offer manufacturers/developers and professionals a clear perspective with respect to the future opportunities associated with POC COVID-19 tests.

Report Highlights

The infectious diseases product segment dominated the global market in 2020 with a share of over 36% and will retain its leading position throughout the forecast years. The glucose product segment is estimated to account for the second-highest revenue share by 2028. Routine testing of glucose levels is of prime importance for the management of diabetic patients. As per the Diabetes Control and Complications Trial, integration of blood glucose monitors results in lesser complications associated with the disease.

Point of care glucose monitors assists in regular monitoring of blood glucose, which further enables doctors to design an effective therapy. Over-the-Counter (OTC) or rapid tests and prescription tests are the POC tests that are useful for the determination of blood glucose levels in hospitals and other POC settings. The growing prevalence of diabetes and the introduction of portable diagnostic equipment are expected to boost the segment growth from 2021 to 2028.

The cardiac markers product segment is expected to register the second-fastest CAGR during the forecast period. High accuracy rates associated with these markers and the growing prevalence of target diseases are the primary drivers of this segment. In addition, hospitals are increasingly relying on the rapid results obtained by cardiac biomarker measurement to proceed with the treatment of individuals with Cardiovascular Disorders (CVDs). Point of care tests are designed to read high troponin values, which further signals the need to admit the individual to the hospital.

The clinics segment accounted for the highest revenue share of over 37% in 2020. Pharmacy & retail clinics are the major contributors to the revenue generated by this segment. Growing access to novel diagnostic technologies, improving healthcare coverage, and affordability are the key factors that are expanding the applications of POC testing.

Thus, community pharmacies and retail clinics have emerged as potential medical setups that perform such lab tests; especially regarding cholesterol and glycosylated hemoglobin (A1C) testing. POC products manufactured by key players that are exclusive to physician office applications also contributed to the revenue of this segment in the global POC diagnostics and testing market.

For instance, Siemens Healthineers showcases a broad portfolio of POC solutions suitable for analytical applications at physicians’ offices; these include diabetes, urinalysis, and coagulation. The company also offers software solutions that help in connecting more than 100 POC devices along with all the operators that utilize them.

On the other hand, the home end-use segment is expected to register the fastest growth rate of 4.01% from 2021 to 2028. POC devices deployed in the home healthcare sector have empowered patients to address healthcare challenges at home and take decisions instantly. The growing emphasis on early detection and prevention of diseases is supplementing the segment’s growth.

North America was the largest regional market in 2020 and accounted for a revenue share of over 34%. The region will retain its dominant position throughout the forecast years on account of rapidly increasing COVID-19 cases in the U.S. and Canada. The number of COVID-19 tests conducted in this region was more than 300 million, thus, offering tremendous scope for market growth.

Key Players

  • F. Hoffmann-La Roche Ltd.

  • Qiagen

  • Danaher Corp.

  • Becton Dickinson (BD)

  • Biomerieux SA

  • Abbott Laboratories

  • Siemens Healthcare AG

  • Zoetis, Inc.

  • Instrumentation Laboratory

  • Nova Biomedical

  • Trividia Health, Inc.

  • Quidel Corp.

  • Trinity Biotech

  • Sekisui Diagnostics

  • Orasure Technologies, Inc.

  • Nipro Corp.

  • Spectral Medical, Inc

Market Segmentation

  • Product Outlook

    • Glucose Testing

    • Hb1Ac Testing

    • Coagulation

    • Fertility

    • Infectious Diseases

      • HIV POC

      • Clostridium Difficile POC

      • HBV POC

      • Pneumonia or Streptococcus Associated Infections

      • Respiratory Syncytial Virus (RSV) POC

      • HPV POC

      • Influenza/Flu POC

      • HCV POC

      • MRSA POC

      • TB and Drug-Resistant TB POC

      • HSV POC

      • COVID-19

      • Other Infectious Diseases

    • Cardiac Markers

    • Thyroid Stimulating Hormone

    • Hematology

    • Primary Care Systems

    • Decentralized Clinical Chemistry

    • Feces

    • Lipid Testing

    • Cancer Marker

    • Blood Gas/Electrolytes

    • Ambulatory Chemistry

    • Drug Abuse Testing

    • Urinalysis

  • End-use Outlook 

    • Clinics

      • Pharmacy & Retail Clinics

      • Physician Office

      • Urgent Care Clinic

      • Non-practice Clinics

    • Hospitals

    • Home

    • Assisted Living Healthcare Facilities

    • Laboratory

  • Regional Outlook

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Korea

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa (MEA)

      • South Africa

      • Saudi Arabia

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

About Us: Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.

We offer generic and amalgamated studies as well as customized studies to our clients based on their specific requirements. Our modus operandi constitutes of detailed and meticulous market surveys, company profiling, competitive landscaping and primary interviews.  Our prudent insights have been vital in the inception of many investment programs, new project development programs, startups and technology breakthroughs.

Contact Us:

Call: +1 9197 992 333

Vision Research Reports

Leave a Reply

Your email address will not be published.